News

Little Green Pharma (ASX:LGP) has some genuine pioneering notches on its belt. Read the article here

We have been granted a new manufacturing permit from the Office of Drug Control. Read more...

Read more on the Australian firm hoping to help more UK patients benefit from medical cannabis.

An Australian first. Read more on our export of medicinal cannabis for UK patients.

On-time and on budget. Read more about our expansion facility here.

Australia's latest listed medicinal cannabis company has launched onto the market with a bang, scoring a major UK distribution deal the night before landing.

Little Green Pharma raised the maximum subscription amount of $10 million in an oversubscribed IPO.

A new study has found that medicinal cannabis may be able to reduce the intensity of chronic pain in patients by as much as 30%.

Little Green Pharma reaches a significant milestone becoming the first Australian medicinal cannabis producer to export samples of locally grown medicinal cannabis product to Germany.

Landmark collaboration to commercialise transdermal cannabis technologies

Little Green Pharma successfully harvest another medical cannabis crop and pass TGO 93.

The company has been granted an Export Licence by the Federal Department of Health

Little Green Pharma (LGP), is the first Australian company to locally-grow and produce medicinal cannabis products for sale to Australian patients. The first products are now ready to be delivered to patients.

Little Green Pharma have sponsored a new digital platform, GreenChoices to provide both medical practitioners and patients with meaningful research and education, with the aim of assisting them make informed choices about medical cannabis as a possible treatment option.